IMV Inc.
IMV
Classement en actions
#35067
IMV Inc. is a clinical-stage biotechnology company dedicated to the development... IMV Inc. is a clinical-stage biotechnology company dedicated to the development of innovative immunotherapies. The company utilizes its proprietary DPX immune-educating technology platform to create a portfolio of treatments for various solid and hematological cancers. Its leading investigational drug, maveropepimut-S, is a DPX-based immunotherapy designed to target cancer cells that express survivin. Maveropepimut-S is currently undergoing Phase II clinical trials for diffuse large B-cell lymphoma, ovarian cancer, and specific bladder, liver, and microsatellite instability-high tumors, with Phase I trials also active for breast cancer. Beyond its primary candidate, IMV is also advancing DPX-SurMAGE, which is in Phase I clinical trials for bladder cancer, and is developing DPX-COVID-19 and DPX-RSV to address infectious diseases. Originally founded in 2000 as Immunovaccine Inc., the company adopted the name IMV Inc. in May 2018 and operates from its headquarters in Dartmouth, Canada.
Prix de l'action
$0.82959892
Dernière synchronisation: 2023-05-23
Capitalisation boursière
$4.16M
Changement (1 jour)
-0.04%
Changement (1 an)
82,959,792.06%
Pays
CA
Échange IMV Inc. (IMV)
Catégorie
Healthcare
Historique du prix de l'action pour IMV Inc. (IMV)
Prix de clôture le plus élevé : $0.00 le 2024-04-01
Prix de clôture le plus bas : $2.79 le 2009-10-01
Prix de clôture le plus bas : $2.79 le 2009-10-01
Historique du prix de l'action de IMV Inc. de 2009 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2024 | -99.62% |
| 2023 | -99.90% |
| 2022 | -80.41% |
| 2021 | -58.37% |
| 2020 | 14.77% |
| 2019 | -48.18% |
| 2018 | 1.97% |
| 2017 | 209.96% |
| 2016 | -4.32% |
| 2015 | -11.63% |
| 2014 | 46.23% |
| 2013 | 3.39% |
| 2012 | 10.27% |
| 2011 | -50.45% |
| 2010 | -42.36% |
| 2009 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $536.74 | 25.87% |
US
|
|
| $227.23 | 746.28% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $881.75 | 8.30% |
NL
|
